OKYO Pharma Limited (OKYO) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OKYO Revenue Growth
OKYO Revenue Analysis (2014–2025)
As of May 8, 2026, OKYO Pharma Limited (OKYO) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, OKYO's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including LNTH (+0.6% YoY), NVCR (+8.5% YoY), and SGHT (+1.8% YoY). Compare OKYO vs LNTH →
OKYO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OKYOCurrent | $0 | - | - | - | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 SGHT | $77M | +1.8% | +22.9% | -48.0% |
OKYO Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-2,563 | - | $-7,188,875 | - |
| 2024 | $0 | - | $-3,866 | - | $-15,694,549 | - |
| 2023 | $0 | - | $-3,797 | - | $-13,087,270 | - |
| 2022 | $0 | - | $-2,423 | - | $-6,231,000 | - |
| 2021 | $0 | - | $-13,086 | - | $-4,133,349 | - |
| 2020 | $0 | - | $-5,971 | - | $-1,518,850 | - |
| 2019 | $0 | - | $-219 | - | $-4,539,000 | - |
| 2018 | $0 | - | $0 | - | $-28,286,000 | - |
| 2017 | $0 | - | $0 | - | $-363,000 | - |
| 2016 | $0 | - | $0 | - | $-1,100,000 | - |
See OKYO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OKYO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OKYO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOKYO — Frequently Asked Questions
Quick answers to the most common questions about buying OKYO stock.
Is OKYO's revenue growth accelerating or slowing?
OKYO TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is OKYO's long-term revenue growth rate?
OKYO Pharma Limited's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is OKYO's revenue distributed by segment?
OKYO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.